Riskpilot← Back to searchSign inGet full accessMEDICUS TRONDHEIM AS
ASActiveOrg 978654657Beddingen 8, 7042 TrondheimMedical specialists activities · NACE 8622Est. 199722 employees
Revenue 2024
NOK 51,3M
+7% vs 2023
EBITDA margin
17.9%
+39% vs 2023
Equity ratio
15.6%
Financial strength
Net profit 2024
NOK 5,6M
+56% vs 2023
| Revenue | NOK 51,3M | +7% |
| EBITDA | NOK 9,2M | +39% |
| Net profit | NOK 5,6M | +56% |
| Total assets | NOK 30,2M | +24% |
| Equity | NOK 4,7M | -3% |
| Employees | 22 | — |
Legal name
MEDICUS TRONDHEIM AS
Org number
978654657
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
1. januar 1997
Share capital
NOK 100 000
Employees
22 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Address
Beddingen 8, 7042 Trondheim
Phone
+4773871470
Email
post@medicus.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 20 281 | 36 066 | 46 308 | 47 830 | 51 299 |
| Staff expenses | −7 379 | −9 384 | −12 346 | −23 681 | −22 920 |
| EBITDA | 2 589 | 8 007 | 7 417 | 6 620 | 9 203 |
| Depreciation & amort. | −67 | −141 | −390 | −1 822 | −1 868 |
| EBIT | 2 522 | 7 866 | 7 027 | 4 798 | 7 335 |
| Net financials | 29 | −110 | −91 | −152 | −100 |
| Profit before tax | 2 551 | 7 756 | 6 936 | 4 645 | 7 235 |
| Tax | 561 | 1 706 | 1 526 | 1 021 | 1 592 |
| Net profit | 1 990 | 6 050 | 5 409 | 3 624 | 5 643 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 481 | 18 315 | 20 944 | 24 333 | 30 217 |
| Equity | 3 677 | 100 | 4 857 | 4 872 | 4 721 |
| Long-term debt | 0 | 3 409 | 5 128 | 5 114 | 2 408 |
| Short-term debt | 3 805 | 14 807 | 10 959 | 14 348 | 23 088 |
| Total debt | 3 805 | 18 215 | 16 087 | 19 461 | 25 496 |
EBITDA margin
17.9%
This company
15.8%
Market median
+13% vs market
20202024
Equity ratio
15.6%
This company
38.2%
Market median
-59% vs market
20202024
Return on equity
119.5%
This company
18.4%
Market median
+549% vs market
20202024
Net profit margin
11.0%
This company
8.1%
Market median
+36% vs market
20202024
Asset turnover
1.70×
This company
1.12×
Market median
+52% vs market
20202024
Debt / equity
5.40×
This company
0.62×
Market median
-771% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Chairman | 2023 | |
| Former (2) | ||
| Chairman | 2021 – 2023 | |
| Board of Directors | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Skeiseid-Klefstad Holding As
MEDICUS TRONDHEIM AS Board members of MEDICUS TRONDHEIM AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Pedersen | Chairman | 0 companies |
| Terje Sørdal | Board of Directors | 0 companies |
| Ann Merethe Lysø Sommerseth | Board of Directors | 0 companies |
| Magnus Finset Sørdal | Chairman | 0 companies |